Amount Raised
$30 Million
Round Type
Series B
DurhamBiotechnologyHealth CareDescription
Incyclix Bio, LLC (formerly Arc Therapeutics, LLC), a next-generation cell cycle control company, today announced the closing of a $30 million Series B financing led by new investor Boxer Capital. Additional new investor RA Capital Management also participated in the round, along with existing investor Eshelman Ventures. Sid Subramony, Ph.D., Vice President of Boxer Capital, will join the Company’s board of directors. Nathaniel Brooks Horwitz, Principal of RA Capital Management, will join Incyclix Bio as a board observer.
Quick answer
Incyclix Bio raised $30 Million in a Series B round, dated March 31, 2022. Incyclix Bio is based in Durham, North Carolina, United States.
- How much did Incyclix Bio raise?
- Incyclix Bio raised $30 Million in a Series B round on March 31, 2022.
- What does Incyclix Bio do?
- Incyclix Bio, LLC is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers.
- Where is Incyclix Bio based and how big is it?
- Incyclix Bio is based in Durham, North Carolina, United States. Fundz records about 10 employees.
- Who are the decision-makers at Incyclix Bio?
- Fundz holds 1 contact at Incyclix Bio, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Incyclix Bio that raised within 45 days of this round, from Fundz verified event records.
- GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.
- Impulse Dynamics raised $101M (Funding Round) on May 12, 2022.
- NanoPhoria raised an undisclosed amount on May 12, 2022.
- Tempest Therapeutics raised $15M on May 11, 2022.
- Sequentify raised $7M (Funding Round) on May 10, 2022.
- Moma Therapeutics raised $150M (Series B) on May 10, 2022.
Who to call at Incyclix Bio, and when
A new round usually means Incyclix Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Incyclix Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Incyclix Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Incyclix Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Incyclix Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansIncyclix Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.